Overview

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

Status:
RECRUITING
Trial end date:
2030-01-19
Target enrollment:
Participant gender:
Summary
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.
Phase:
PHASE2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Strategic Alliance
Summit Therapeutics